Literature DB >> 28919387

Health-related quality of life in adolescents with epilepsy in Montenegro.

Nelica Ivanović Radović1, Ksenija Božić2, Aleksandra Plećaš Đurić3, Sanja Vodopić4, Ljiljana Radulović4, Slavica Vujisić5.   

Abstract

OBJECTIVE: The objective of this study was to establish potential risk factors for poor health-related quality of life among adolescents with epilepsy in Montenegro.
MATERIAL AND METHODS: A sample of 104 adolescents with epilepsy (age: 11-19years) at a tertiary referral center in Podgorica, Montenegro, completed the validated Serbian version of the QOLIE-AD-48 questionnaire. They were divided into two groups: a group with active epilepsy (60 adolescents) and a group with inactive epilepsy (44 adolescents). Demographic and clinical data were collected.
RESULTS: Adolescents with active epilepsy had low quality of life and felt the negative impact of the disease. They also had more cognitive impairments, felt more stigmatized, and had considerably more distorted perception of their health than adolescents with inactive epilepsy (p<0.05). Females reported better social support than males (p<0.05). Older males had lower grades at school (p<0.05) than the younger ones. As expected, adolescents with the highest number of seizures in the past two years had the lowest quality of life (p<0.05).
CONCLUSION: In our study, the quality of life in adolescents with epilepsy was determined by severity of the disease, age, and gender.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent; Epilepsy; Montenegro; QOLIE-AD-48; Quality of life

Mesh:

Year:  2017        PMID: 28919387     DOI: 10.1016/j.yebeh.2017.07.009

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  1 in total

1.  Effects of insomnia and levels of depression and anxiety symptoms on quality of life in people with epilepsy.

Authors:  Rui Zhong; Zhuan Li; Qingling Chen; Hanyu Zhang; Xinyue Zhang; Weihong Lin
Journal:  BMC Psychiatry       Date:  2022-07-25       Impact factor: 4.144

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.